REM Analytics SA is a Swiss precision microbiome diagnostics company commercializing the proprietary ATGC® platform — a capillary electrophoresis technology delivering strain-level microbial identification at ±3% accuracy, outperforming standard sequencing at a fraction of the cost. Our CE-IVD certified assays address high-value clinical markets: vaginal microbiome (women's health, fertility, menopause) and gut-brain axis diagnostics (Bifidobacterium profiling for mental health and nutrition). Revenue streams combine per-test sales, custom assay development services, and instrument licensing via the Cello 96-capillary system (~CHF 113K/unit + recurring consumables). Products are actively deployed in Switzerland, Brazil, Italy, Spain and Japan.
Swiss life science startups headed for San Diego (startupticker.ch)
The Startup Champions Seed Night 2020 showcased 18 promising startups in a hybrid event (venturelab.swiss)
Pitch Startup Champions Seed Night 2020